Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Pfizer Inc. (PFE)

33.94   0.77 (2.32%) 10-02 16:00
Open: 32.95 Pre. Close: 33.17
High: 33.955 Low: 32.765
Volume: 39,514,343 Market Cap: 191,624(M)

Technical analysis

as of: 2023-10-02 4:52:25 PM
Short-term rate:       
Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time.
Mid-term rate:       
Target: Six months: 40.84     One year: 43.14
Support: Support1: 31.77    Support2: 26.43
Resistance: Resistance1: 34.96    Resistance2: 36.93
Pivot: 33.32
Moving Average: MA(5): 32.73     MA(20): 33.6
MA(100): 36.34     MA(250): 41.31
MACD: MACD(12,26): -0.8     Signal(9): -0.8
Stochastic oscillator: %K(14,3): 45.4     %D(3): 24.8
RSI: RSI(14): 49.5
52-week: High: 54.93  Low: 31.77
Average Vol(K): 3-Month: 24,616 (K)  10-Days: 29,067 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ PFE ] has closed below upper band by 29.2%. Bollinger Bands are 4.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 34.01 - 34.18 34.18 - 34.32
Low: 32.37 - 32.55 32.55 - 32.73
Close: 33.62 - 33.94 33.94 - 34.23

Company Description

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Headline News

Mon, 02 Oct 2023
Should You Hold Pfizer Inc. (PFE) Stock Monday? - InvestorsObserver

Mon, 02 Oct 2023
Pfizer Inc. (NYSE: PFE): PFE Stock Price Breaks the $34.98 Level - The Market Periodical

Mon, 02 Oct 2023
Pfizer and GSK's New RSV Vaccines On Track For $2 Billion in Sales - Bloomberg

Fri, 29 Sep 2023
Pfizer Inc. stock outperforms competitors on strong trading day - MarketWatch

Wed, 27 Sep 2023
Pfizer Inc. stock outperforms competitors despite losses on the day - MarketWatch

Wed, 27 Sep 2023
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending ... - Nasdaq

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers—General
Shares Out. 5,650 (M)
Shares Float 5,640 (M)
% Held by Insiders 0 (%)
% Held by Institutions 70.7 (%)
Shares Short 50,460 (K)
Shares Short P.Month 45,860 (K)

Stock Financials

EPS 3.75
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 17.54
Profit Margin (%) 27.5
Operating Margin (%) 32.5
Return on Assets (ttm) 7.6
Return on Equity (ttm) 23
Qtrly Rev. Growth -54.1
Gross Profit (p.s.) 11.72
Sales Per Share 13.79
EBITDA (p.s.) 5.49
Qtrly Earnings Growth -76.5
Operating Cash Flow 14,560 (M)
Levered Free Cash Flow 12,350 (M)

Stock Valuations

PE Ratio 9.02
PEG Ratio -0.7
Price to Book value 1.93
Price to Sales 2.46
Price to Cash Flow 13.17

Stock Dividends

Dividend 0.4
Forward Dividend 0
Dividend Yield 1.2%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.